{'fraction_non_alphanumeric': 0.018867924528301886, 'fraction_numerical': 0.0, 'mean_word_length': 4.96875, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Glioblastoma Drug Treatments and Animal Models

Glioblastoma is a malignant tumor that is seen in the cerebral hemispheres, cerebellum, spinal cord and brain stem. This tumor, which follows an invasive approach, consists of the cells called astrocytes that form the most important part of the glia cells. When the disease arises, the neurons are directly affected and neurotransmitter substances cannot fulfill their functions, as well as a memory damage may occur. Studies have been conducted on experimental animals in order to perform better analysis in the treatment for years. As a result of studies on rat and mouse models, it has been proven that drugs such as irinotecan, bevacizumab, temozolomide and their active ingredients are promising for patients. In this review, it is aimed to reveal how glioblastoma emerged, its diseases and symptoms by working step by step on animal models of rats and mice, and to expand the field of drug treatment.